Technologies
Spatial biology technologies we analyze
From in situ transcriptomics to multiplexed protein imaging, mass spectrometry imaging and digital pathology: what each platform is good at, and how we can help you get answers from it.
Spatial transcriptomics
Xenium
Imaging-based, subcellular spatial transcriptomics with targeted panels.
Learn more →CosMx
Imaging-based single-cell RNA and protein, up to whole-transcriptome panels.
Learn more →GeoMx DSP
Region- and compartment-level whole-transcriptome or protein profiling.
Learn more →Visium & Visium HD
Sequencing-based whole-transcriptome spatial data aligned to H&E.
Learn more →MERSCOPE
MERFISH imaging of targeted gene panels across large tissue areas.
Learn more →Stereo-seq (STOmics)
Whole-transcriptome capture at sub-micron spacing over large areas.
Learn more →Multiplexed protein imaging
PhenoCycler (CODEX)
Cyclic, DNA-barcoded antibody imaging of 40 to 100+ markers.
Learn more →Imaging mass cytometry
Metal-tagged antibodies imaged by laser ablation, around 40 markers.
Learn more →COMET
Automated sequential immunofluorescence with standard antibodies.
Learn more →PhenoImager & Opal
Opal multiplex IF with multispectral unmixing, widely used in trials.
Learn more →Also: Orion (RareCyte), MACSima (Miltenyi), MIBI, inForm, HALO, Visiopharm, Cellpose, StarDist and Segment Anything.
Not sure which platform fits your question?
We can help you choose, design the study, or make sense of data you already have.